HomeAI · summaries
Storia in 3 fonti
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Takeda detailed its latest restructuring and Alumis is discarding a once-highly touted immune drug.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
With a new CEO prepared to take the reins next month and three key launches on deck for 2026 and 2027, Takeda is ready to shake off the generic-related declines that have plagued…
- ·
Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top…
- ·
biopharmadive.com
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Takeda detailed its latest restructuring and Alumis is discarding a…
- ·
pharmaceutical-technology.com
Biopharma industry endorses Pazdur for FDA commissioner role - Pharmaceutical Technology
Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.